Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, ... Indaptus Therapeutics, Inc., a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as chronic hepatitis B virus and human immunodeficiency virus infection, which is in Phase 2 clinical trial. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.012 | -1.51133501259 | 0.794 | 0.8409 | 0.7012 | 9481 | 0.78627055 | CS |
| 4 | -0.108 | -12.1348314607 | 0.89 | 0.96 | 0.7012 | 28788 | 0.80180513 | CS |
| 12 | -0.278 | -26.2264150943 | 1.06 | 1.06 | 0.7012 | 23920 | 0.86857829 | CS |
| 26 | -0.838 | -51.7283950617 | 1.62 | 2.08 | 0.7012 | 70394 | 1.56377214 | CS |
| 52 | -1.528 | -66.1471861472 | 2.31 | 3.1 | 0.7012 | 61219 | 1.90063924 | CS |
| 156 | -3.338 | -81.0194174757 | 4.12 | 4.3 | 0.7012 | 73367 | 2.57540164 | CS |
| 260 | -9.318 | -92.2574257426 | 10.1 | 28.8299 | 0.7012 | 368058 | 9.07029612 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
